Category IP Policies

UN Rapporteur For Privacy Rebuffed On Surveillance Oversight Negotiations

The United States, China and the European Union were unanimous yesterday in their rejection of international consultations for a possible legal instrument on government-led surveillance and privacy. During the 19th meeting of the 37th session of the UN Human Rights Council in Geneva, they called a possible legal instrument against uncontrolled cross-border surveillance proposed by the UN Special Rapporteur on Privacy, Joseph Cannataci, “unnecessary.” But Cannataci responded that the problems cannot be ignored.

EPO Reports Record Volume Of Patents, Seeks To Assure Quality

The European Patent Office today issued statistics which it claimed show the continued ascendance of Europe as a premier destination for patenting, not only from European countries. The statistics focus strongly on the increased volume of patents filed and granted, which it argued is a result of the office's focus on "efficiency and quality" and a boost to innovation.

Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America

The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide.

Early Certainty Initiative Of The European Patent Office – Flexibility For Biotech Needed

In 2016, the European Patent Office (EPO) introduced a streamlined opposition procedure that should simplify opposition proceedings and deliver decisions faster, while giving parties more time to react to summons and prepare for oral proceedings. This new initiative, called early certainty, aimed to cut down the overall duration of granting new patents and to tackle the backlog in patent granting within the EPO, writes Michael Kahnert.

Today – UN Human Rights Council To Hear Rapporteur’s Report On Government Surveillance Online

The United Nations Human Rights Council today (6 March) is expected to hear a report on government surveillance to be presented by the UN special rapporteur on the right to privacy. The report calls for the urgent development of a comprehensive legal framework on privacy and surveillance in cyberspace.

USTR Lighthizer To NAFTA Partners: Step Up Pace Or Lose Window Of Opportunity

United States Trade Representative Robert Lighthizer warned his Mexican and Canadian counterparts today (5 March) that if they don't quickly pick up the pace of the North American Free Trade Agreement (NAFTA) renegotiations, they will face "headwinds" from elections in all three countries. And if they can't progress, the US is prepared to proceed bilaterally.

USPTO To Reveal New Design For Patents This Week

The United States Patent and Trademark Office (USPTO) will make public the new design for patents this week at the South by Southwest (SXSW) Interactive Festival in Austin, Texas. The new design will first be used on patent number 10 million, expected to issue this year. There have fewer than 12 basic design changes to the US patent since President George Washington granted the first patent in 1790, and only two in the last 100 years, USPTO said.

Tough Talk On Transatlantic Privacy, Once Again

The EU Commissioner for Justice, Consumers and Gender Equality, Věra Jourová, ahead of her US visit announced “a tough tone” on remaining gaps in the implementation of the privacy shield, the arrangement that allows to transfers of data of EU citizens to the United States. Speaking before the EU Parliament's Committee on Civil Liberties (LIBE), Jourová said while she had heard the privacy shield was not a priority of the US administration, “it will be a priority, if we make clear that we will suspend the system if it doesn't work,” adding, “My patience is coming to an end.”

A Look At The Role Of Governments, Universities, Science In Health Innovation & Access

Intellectual property rights, particularly patents, are considered by some as being a barrier in access to medicines despite being a stimulus for innovation. At a recent symposium co-organised by the World Health Organization, World Trade Organization and World Intellectual Property Organization, speakers also talked about the role of science, governments, and universities in health innovation and access, and how to address challenges such as secondary patents.